Disease/Infection News

RSS

New pair of techniques can speed up the search for better tuberculosis drugs

Tuberculosis, caused by the bacterium Mycobacterium tuberculosis (Mtb) is the world's deadliest single-agent caused infection, responsible for 1.23 million deaths in 2024, according to the World Health Organization.

6 Jul 2026

New viral insights lay foundation for treating infection with JC polyomaviruses

In people with severely compromised immune systems, the JC polyomavirus can trigger a currently untreatable, usually fatal brain disease.

6 Jul 2026

New HIV vaccine successfully generates broadly neutralizing antibodies in primates

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the potential to protect humans from developing HIV infection and AIDS.

6 Jul 2026

Korea University College of Medicine selected as the lead institution for hantavirus vaccine development project

The Vaccine Innovation Center at Korea University College of Medicine has been selected by the Korea Disease Control and Prevention Agency (KDCA) as the lead institution for a national hantavirus vaccine development project.

6 Jul 2026

Memory B cells reveal how nasal vaccines could stop respiratory infections earlier

A Science Immunology Review explains how memory B cells acquire diverse molecular, epigenetic, and tissue-specific programs that shape long-term immune protection. It highlights lung-resident memory B cells as a key target for mucosal vaccines, potentially improving control of airborne infections and reducing transmission.

6 Jul 2026

Anti-lipid antibodies could improve early testing for Lyme disease

Lyme disease can be easiest to treat in its earliest stages, but current tests often miss infections during that critical window and cannot tell whether bacteria are still present or were cleared years ago.

6 Jul 2026

WHO launches PARTNERS clinical trial for Bundibugyo virus treatments

In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the PARTNERS clinical trial has opened enrolment today for patients in the Democratic Republic of the Congo.

3 Jul 2026

WHO lists first molecular diagnostic test for Bundibugyo virus

Today, the World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL).

3 Jul 2026

Can ibuprofen improve drug-resistant tuberculosis treatment?

While ibuprofen reduced inflammatory markers in drug-resistant TB patients, it did not enhance treatment outcomes, indicating the need for further research.

3 Jul 2026

Move to quit: Exercise boosts smoking quit rates

A pack-a-day smoker can spend around $14,000 a year on cigarettes, yet despite the financial and health costs, quitting remains one of the most difficult changes many people will ever attempt.

3 Jul 2026

Overlooked parasitic disease linked to HIV and cervical cancer risk

New research from Liverpool School of Tropical Medicine (LSTM) has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.

3 Jul 2026

Cat fleas may contribute to murine typhus transmission in Texas

As human cases of flea-borne murine typhus continue to occur in South Texas, researchers are working to better understand the role cats and their fleas may play in the disease's transmission cycle.

2 Jul 2026

Foodborne threats demand stronger pandemic planning, review says

A Perspective review in npj Science of Food argues that pandemics can weaken food safety systems even when the pathogen is not foodborne. The authors call for One Health planning that integrates food safety into pandemic preparedness, surveillance, laboratory capacity, workforce readiness, and regulation.

2 Jul 2026

Study links biodiversity loss to rising hantavirus spillover risk

No rodents were found aboard. The confined vessel, carrying 147 people from 23 countries, became an unexpected amplifier of person‑to‑person transmission.

2 Jul 2026

New grants advance AI-powered wastewater pathogen surveillance

Detecting infectious disease threats early and responding quickly can dramatically alter the course of an infectious outbreak.

2 Jul 2026

Study tracks long-term recovery patterns of COVID-19 patients

Six years after the world first learned of COVID-19, the pandemic has faded into an unpleasant memory for many. For others, however, it never fully ended.

2 Jul 2026

Decades of research reveal surprising secrets about hantavirus evolution

Thirty years ago, it was our common sense understanding that hantavirus does not and perhaps cannot spread from human to human. It turns out there is one exception: a strain called the Andes virus.

2 Jul 2026

KFF poll finds vaccine myths reach many Americans but convince few

KFF’s 2026 tracking poll found that many U.S. adults have heard common vaccine myths, including false claims about MMR, COVID-19, mRNA vaccines, and measles vaccines. Fewer adults strongly believe these myths, but a large, uncertain “malleable middle” remains, especially among those without a trusted health care provider, frequent social media users, some AI health-information users, and parents who delayed or skipped childhood vaccines.

1 Jul 2026

New labeling scheme could reduce Listeria infections from ready-to-eat foods

Listeria infections are on the rise, and around 15% of people in the EU who contract the infection die from it.

1 Jul 2026

Flavonoid-rich foods may blunt breast cancer risk tied to genetics

Higher flavodiet scores were associated with lower breast cancer risk among 93,271 UK Biobank females followed for a median of 11.8 years. The inverse association was particularly evident in women with high genetic risk, but the observational study cannot prove causation.

1 Jul 2026